Please login to the form below

Not currently logged in


This page shows the latest cardiovascular news and features for those working in and with pharma, biotech and healthcare.

FDA advisory committee votes against approval of AZ, FibroGen's roxadustat

FDA advisory committee votes against approval of AZ, FibroGen's roxadustat

The FDA’s cardiovascular and renal drugs advisory committee (CRDAC) has voted 13 to one that the benefit-risk profile of roxadustat does not support approval for the treatment of anaemia ... According to analysis included in the FDA briefing documents,

Latest news

More from news
Approximately 45 fully matching, plus 957 partially matching documents found.

Latest Intelligence

More from intelligence
Approximately 1 fully matching, plus 83 partially matching documents found.

Latest appointments

More from appointments
Approximately 0 fully matching, plus 59 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 3 fully matching, plus 56 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs


Add my company
Create Health

A healthcare marketing agency that shares your passion for making things better. Our clients with solve real health problems every...

Latest intelligence

Robust Review: COVID19 Assessment
See how our client utilized Rapid Payer Response (RPR) to stay informed and gain continuous insights during the recent global pandemic (COVID19)...
Human behaviour - Sept 21
All change – how untangling human behaviour can encourage better health
Driving better patient outcomes through clear, achievable practical steps that are underpinned by transparent evidence...
Health literacy in the time of COVID-19
In a time when much of the media’s focus is on the ongoing COVID-19 pandemic and the differences in vaccination rates between various regions, countries, and socioeconomic groups, improving health...